A Phase 2/3, Multicenter, randomized, double-blind, placebo-controlled, study to evaluate the safety and efficacy of Alpha-! Antitrypsin for the Prevention of GVHD

Administered By

Awarded By

Contributors

Start/End

  • February 15, 2019 - February 14, 2024